Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1987 Aug;206(2):115–125. doi: 10.1097/00000658-198708000-00001

Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production, and survival.

I Norheim, K Oberg, E Theodorsson-Norheim, P G Lindgren, G Lundqvist, A Magnusson, L Wide, E Wilander
PMCID: PMC1493111  PMID: 2440390

Abstract

In a prospective study of 103 patients with carcinoid tumors consecutively referred for medical treatment, the most common sites of the primary tumors were the ileum (73%), bronchi (7%), and jejunum (4%). All patients had local metastases, and 96 (93%) also had liver metastases. The most common initial symptoms were diarrhea (32%), ileus (25%), and flush (23%). The overall frequency of diarrhea was 84% and of flush was 75%. Heart insufficiency caused by cardiac valve disease was seen in 33% of the patients. The carcinoid syndrome, including flush, diarrhea, and elevated urinary 5-hydroxyindole acetic acid (5-HIAA) concentrations, was manifested by 69 patients (67%), 64 of whom (93%) had carcinoid tumors of mid-gut origin. Elevated urinary 5-HIAA was found in 91 patients (88%), of which 89 displayed liver metastases. The plasma concentration of the tachykinin neuropeptide K (NPK) was elevated in 67 patients (66%), 63 of whom had tumors of the mid-gut region. Serum pancreatic polypeptide (PP) and human chorionic gonadotrophin alpha levels were elevated in 43% and 28% of the patients, respectively, and the highest levels were found in patients with metastatic bronchial carcinoid tumors. Thirty-nine of the 103 patients are now dead; 18 died of tumor progression, whereas 14 patients died of heart failure secondary to a carcinoid tricuspidal valve insufficiency. The estimated median survival from the time of histologic diagnosis was 14 years, and from the time of carcinoid syndrome was 8 years.

Full text

PDF
115

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahlman H., Dahlström A., Grönstad K., Tisell L. E., Oberg K., Zinner M. J., Jaffe B. M. The pentagastrin test in the diagnosis of the carcinoid syndrome. Blockade of gastrointestinal symptoms by ketanserin. Ann Surg. 1985 Jan;201(1):81–86. [PMC free article] [PubMed] [Google Scholar]
  2. Almqvist S., Telenius-Berg M., Wästhed B. Serum calcitonin in medullary thyroid carcinoma. Radioimmunoassay technique and diagnostic value. Acta Med Scand. 1974 Sep;196(3):177–180. doi: 10.1111/j.0954-6820.1974.tb00992.x. [DOI] [PubMed] [Google Scholar]
  3. Barclay T. H., Schapira D. V. Malignant tumors of the small intestine. Cancer. 1983 Mar 1;51(5):878–881. doi: 10.1002/1097-0142(19830301)51:5<878::aid-cncr2820510521>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  4. Berge T., Linell F. Carcinoid tumours. Frequency in a defined population during a 12-year period. Acta Pathol Microbiol Scand A. 1976 Jul;84(4):322–330. [PubMed] [Google Scholar]
  5. Consolazione A., Milstein C., Wright B., Cuello A. C. Immunocytochemical detection of serotonin with monoclonal antibodies. J Histochem Cytochem. 1981 Dec;29(12):1425–1430. doi: 10.1177/29.12.7033368. [DOI] [PubMed] [Google Scholar]
  6. Dabek F. T. Bronchial carcinoid tumour with acromegaly in two patients. J Clin Endocrinol Metab. 1974 Feb;38(2):329–333. doi: 10.1210/jcem-38-2-329. [DOI] [PubMed] [Google Scholar]
  7. Davis Z., Moertel C. G., McIlrath D. C. The malignant carcinoid syndrome. Surg Gynecol Obstet. 1973 Oct;137(4):637–644. [PubMed] [Google Scholar]
  8. Dawes L., Schulte W. J., Condon R. E. Carcinoid tumors. Arch Surg. 1984 Apr;119(4):375–378. doi: 10.1001/archsurg.1984.01390160011002. [DOI] [PubMed] [Google Scholar]
  9. Feldman J. M., Jones R. S. Carcinoid syndrome from gastrointestinal carcinoids without liver metastasis. Ann Surg. 1982 Jul;196(1):33–37. doi: 10.1097/00000658-198207000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Goedert M., Otten U., Suda K., Heitz P. U., Stalder G. A., Obrecht J. P., Holzach P., Allgöwer M. Dopamine, norepinephrine and serotonin production by an intestinal carcinoid tumor. Cancer. 1980 Jan 1;45(1):104–107. doi: 10.1002/1097-0142(19800101)45:1<104::aid-cncr2820450119>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  11. Grahame-Smith D. G. The carcinoid syndrome. Am J Cardiol. 1968 Mar;21(3):376–387. doi: 10.1016/0002-9149(68)90142-2. [DOI] [PubMed] [Google Scholar]
  12. Grimelius L. A silver nitrate stain for alpha-2 cells in human pancreatic islets. Acta Soc Med Ups. 1968;73(5-6):243–270. [PubMed] [Google Scholar]
  13. Hällgren R., Lundqvist G., Chance R. E. Serum levels of human pancreatic polypeptide in renal disease. Scand J Gastroenterol. 1977;12(8):923–927. doi: 10.3109/00365527709181351. [DOI] [PubMed] [Google Scholar]
  14. Lindgren P. G. Percutaneous needle biopsy. A new technique. Acta Radiol Diagn (Stockh) 1982;23(6):653–656. doi: 10.1177/028418518202300621. [DOI] [PubMed] [Google Scholar]
  15. Lundqvist G., Wide L. Serum gastrin determination with a radioimmunosorbent technique. Clin Chim Acta. 1977 Sep 1;79(2):357–362. doi: 10.1016/0009-8981(77)90429-6. [DOI] [PubMed] [Google Scholar]
  16. Lundqvist M., Wilander E. Subepithelial neuroendocrine cells and carcinoid tumours of the human small intestine and appendix. A comparative immunohistochemical study with regard to serotonin, neuron-specific enolase and S-100 protein reactivity. J Pathol. 1986 Feb;148(2):141–147. doi: 10.1002/path.1711480204. [DOI] [PubMed] [Google Scholar]
  17. Mårtensson H., Nobin A., Sundler F. Carcinoid tumors in the gastrointestinal tract--an analysis of 156 cases. Acta Chir Scand. 1983;149(6):607–616. [PubMed] [Google Scholar]
  18. Nilsson J., von Euler A. M., Dalsgaard C. J. Stimulation of connective tissue cell growth by substance P and substance K. Nature. 1985 May 2;315(6014):61–63. doi: 10.1038/315061a0. [DOI] [PubMed] [Google Scholar]
  19. Norheim I., Theodorsson-Norheim E., Brodin E., Oberg K., Lundqvist G., Rosell S. Antisera raised against eledoisin and kassinin detect elevated levels of immunoreactive material in plasma and tumor tissues from patients with carcinoid tumors. Regul Pept. 1984 Nov;9(4):245–257. doi: 10.1016/0167-0115(84)90076-4. [DOI] [PubMed] [Google Scholar]
  20. Norheim I., Theodorsson-Norheim E., Brodin E., Oberg K. Tachykinins in carcinoid tumors: their use as a tumor marker and possible role in the carcinoid flush. J Clin Endocrinol Metab. 1986 Sep;63(3):605–612. doi: 10.1210/jcem-63-3-605. [DOI] [PubMed] [Google Scholar]
  21. Oates J. A., Pettinger W. A., Doctor R. B. Evidence for the release of bradykinin in carcinoid syndrome. J Clin Invest. 1966 Feb;45(2):173–178. doi: 10.1172/JCI105329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Oberg K., Funa K., Alm G. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome. N Engl J Med. 1983 Jul 21;309(3):129–133. doi: 10.1056/NEJM198307213090301. [DOI] [PubMed] [Google Scholar]
  23. Oberg K., Grimelius L., Lundqvist G., Lörelius L. E. Update on pancreatic polypeptide as a specific marker for endocrine tumours of the pancreas and gut. Acta Med Scand. 1981;210(3):145–152. doi: 10.1111/j.0954-6820.1981.tb09792.x. [DOI] [PubMed] [Google Scholar]
  24. Oberg K., Norheim I., Wide L. Serum growth hormone in patients with carcinoid tumours; basal levels and response to glucose and thyrotrophin releasing hormone. Acta Endocrinol (Copenh) 1985 May;109(1):13–18. doi: 10.1530/acta.0.1090013. [DOI] [PubMed] [Google Scholar]
  25. Oberg K., Wide L. hCG and hCG subunits as tumour markers in patients with endocrine pancreatic tumours and carcinoids. Acta Endocrinol (Copenh) 1981 Oct;98(2):256–260. doi: 10.1530/acta.0.0980256. [DOI] [PubMed] [Google Scholar]
  26. Oberg K., Wide L. hCG and hCG subunits as tumour markers in patients with endocrine pancreatic tumours and carcinoids. Acta Endocrinol (Copenh) 1981 Oct;98(2):256–260. doi: 10.1530/acta.0.0980256. [DOI] [PubMed] [Google Scholar]
  27. PERNOW B., SILWER H., WALDENSTROM J. Case of metastasizing carcinoma (argentaffinoma?) of unknown origin showing peculiar red flushing and increased amounts of histamine and 5-hydroxy-tryptamine in blood and urine. Acta Med Scand. 1956 Dec 8;156(2):73–83. doi: 10.1111/j.0954-6820.1956.tb00517.x. [DOI] [PubMed] [Google Scholar]
  28. SEVIER A. C., MUNGER B. L. TECHNICAL NOTE: A SILVER METHOD FOR PARAFFIN SECTIONS OF NEURAL TISSUE. J Neuropathol Exp Neurol. 1965 Jan;24:130–135. doi: 10.1097/00005072-196501000-00012. [DOI] [PubMed] [Google Scholar]
  29. SINGH I. A MODIFICATION OF THE MASSON-HAMPERL METHOD FOR STAINING OF ARGENTAFFIN CELLS. Anat Anz. 1964 Jul 31;115:81–82. [PubMed] [Google Scholar]
  30. Sandler M., Karim S. M., Williams E. D. Prostaglandins in amine-peptide-secreting tumours. Lancet. 1968 Nov 16;2(7577):1053–1054. doi: 10.1016/s0140-6736(68)91528-6. [DOI] [PubMed] [Google Scholar]
  31. Scheithauer B. W., Carpenter P. C., Bloch B., Brazeau P. Ectopic secretion of a growth hormone-releasing factor. Report of a case of acromegaly with bronchial carcinoid tumor. Am J Med. 1984 Apr;76(4):605–616. doi: 10.1016/0002-9343(84)90284-5. [DOI] [PubMed] [Google Scholar]
  32. Steel K., Baerg R. D., Adams D. O. Cushing's syndrome in association with a carcinoid tumor of the lung. J Clin Endocrinol Metab. 1967 Sep;27(9):1285–1289. doi: 10.1210/jcem-27-9-1285. [DOI] [PubMed] [Google Scholar]
  33. Theodorsson-Norheim E., Norheim I., Oberg K., Brodin E., Lundberg J. M., Tatemoto K., Lindgren P. G. Neuropeptide K: a major tachykinin in plasma and tumor tissues from carcinoid patients. Biochem Biophys Res Commun. 1985 Aug 30;131(1):77–83. doi: 10.1016/0006-291x(85)91772-3. [DOI] [PubMed] [Google Scholar]
  34. WILLIAMS E. D., SANDLER M. The classification of carcinoid tum ours. Lancet. 1963 Feb 2;1(7275):238–239. doi: 10.1016/s0140-6736(63)90951-6. [DOI] [PubMed] [Google Scholar]
  35. Wahlund K. G., Edlén B. Simple and rapid determination of 5-hydroxyindole-3-acetic acid in urine by direct injection on a liquid chromatographic column. Clin Chim Acta. 1981 Feb 19;110(1):71–76. doi: 10.1016/0009-8981(81)90302-8. [DOI] [PubMed] [Google Scholar]
  36. Wilander E., Lundqvist M., Movin T. S-100 protein in carcinoid tumours of appendix. Acta Neuropathol. 1985;66(4):306–310. doi: 10.1007/BF00690963. [DOI] [PubMed] [Google Scholar]
  37. Zeitels J., Naunheim K., Kaplan E. L., Straus F., 2nd Carcinoid tumors: a 37-year experience. Arch Surg. 1982 May;117(5):732–737. doi: 10.1001/archsurg.1982.01380290176031. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES